national clinical guideline template · web viewall documentation should be provided in word...
TRANSCRIPT
National Clinical Guideline Template
Interim Guidance for Guideline Development Groups for the drafting of full version National Clinical
Guidelines
National Clinical Effectiveness CommitteeMay 2014
The following document contains interim guidance regarding the preparation of NCEC approved full version National Clinical Guidelines for Department of Health publication
Checklist May 2014 NCEC approved guidelines should be provided in line with the template provided in the NCEC
Guideline Development Manual (20131). Following final approval of the guideline by the NCEC the Clinical Effectiveness Unit, Department of Health will manage typesetting, preparation for web publication and launch of document in collaboration with the guideline development group. All documentation should be provided in word format.
Guidelines will be published in the NCEC format and colours to provide for easy recognition by the public, clinicians and service providers of National Clinical Guidelines approved by the Minister for Health. Examples of published guidelines, guideline summaries and leaflets are available at http://health.gov.ie/patient-safety/ncec/national-clinical-guidelines/
Guideline Development Groups will be asked to read and sign off final typeset document prior to publication.
Box 1 outlines essential checks that guideline development groups should complete prior to submitting the final approved guideline for typesetting.
The remainder of this document has the preferred NCEC guideline full version National Clinical Guideline template that can be used by the Guideline Development Group(GDG) to populate with their recommendations and findings.
A summary National Clinical Guideline document is also available from the NCEC for completion by the GDG.
The appendices outlined in the template below can be supplemented by any additional appendices as determined by the GDG and relevant content expertise.
More information on the process for NCEC approval can be found in the following framework: National Clinical Effectiveness Committee Framework for Endorsement of National Clinical Guidelines
Box 1: Summary Checklist for completion of a National Clinical GuidelineComplet
1 http://health.gov.ie/wp-content/uploads/2014/03/ncec_guideline_development_manual_january13.pdf
2
eYes/No
1. Recommendations
List who is responsible for implementation of recommendation. This may differ according to the location where care is provided (e.g. hospital versus community setting).Provide grade of recommendation beside each recommendation.Check for difference between recommendations and practical guidance.
2. Guideline editing
Check:- For typographical and grammatical errors.- Type font used is Century Gothic, Size 11 for body of text.- The type font of paragraphs is justified throughout.- Technical aspects for accuracy e.g. double check dosages and
therapies recommended.- Consistency of terminology.- Use of capitals throughout guideline and summary document.- All main and section headings only capitalise the first word.- All abbreviations have been listed.- References are in line with Harvard method. Ideally the reference
software Endnote should be utilised.- Web links are active in both text and references.- Numbering of sections and cross reference with table of contents.- Any cross-referencing in and between documents is accurate.- Website links are live and current.- Appendices are listed numerically (1, 2, 3, etc.)- The colour scheme is as presented in the template document
below.3. Summary
guidelineA short summary of the guideline should be presented using the template provided by the NCEC.
4. Leaflets A patient and a clinician leaflet should be developed for publication as appropriate.
5. Copyright or permissions
Permissions for use of all diagrams etc. should be sought and copies of permissions provided to the DoH.
6. Disclaimers Include disclaimers as required.7. Logos Supply any additional logos required.8. Implementation
monitoring Identified KPIs (guideline implementation and guideline impact) which are suitable for incorporation in HSE Quality and Patient Safety Accountability Framework or HSE Service Plan or other as appropriate.
9. Abbreviations Guideline Development Group (GDG) is the term to be used for the group developing the guideline.
National Clinical Guideline is the term to be used when referring to the guideline in the document.
The full version National Clinical Guideline is how the main document should be referred to.
The summary National Clinical Guideline is how the summary document should be referred to.
10. Alignment The GDG should ensure that their National Clinical Guideline aligns with approved National Clinical Guidelines.
3
Copyright and publicationCopyright of a National Clinical Guideline approved by NCEC and published by the Department of Health lies with the Department of Health. However, the Department of Health acknowledges the work and ownership of any material developed by the Guideline Development Group (GDG). The GDG are requested to consult the Department of Health in advance of any proposed publication. The Department of Health will have twenty (20) working days to review and comment on the proposed publication, during which they may, acting reasonably:
i. recommend changes; and/or
ii. require the removal of any confidential information and/or proprietary information owned by the Department; and/or
iii. request the removal of any material which, in the opinion of the Department, is of a sensitive nature.
Reference must be made to the full title of the published National Clinical Guideline including ISSN and web address of on Department of Health website in all subsequent papers or publications.
4
Guideline Development Group<who is involved and context of members><GDG logos etc>
Using this National Clinical Guideline<intended user group><intended audience><Where the guideline is available><How does the guideline fit in the context of the current healthcare agenda, in terms of the clinical programmes><Key acknowledgements and thanks><signature of the GDG Chair>
Reference of National Clinical Guideline<National Clinical Guideline should be referenced as follows: Department of Health. <Title> National Clinical Guideline No. X. Month. Year. ISSN>
6
National Clinical Effectiveness Committee (NCEC)
<purpose and mission statement to be added by NCEC>
Disclaimer<Example: Healthcare staff should use clinical judgement, medical and nursing knowledge in applying the guidance above and give due regard to individual circumstances presented by each patient/resident and available resources.
Recommendations may not be appropriate in all circumstances and the decision to adopt specific recommendations should be made by the practitioner taking into account the individual circumstances presented by each patient/resident and available resources. Therapeutic options should be discussed with xxx on a case-by-case basis as necessary.>
7
Table of Contents
SECTION 1: BACKGROUND 71.1 Need for National Clinical Guideline/revised National Clinical Guideline 71.2 Clinical and financial impact of condition/disease/topic 71.3 Overview of epidemiology of condition/disease/topic 71.4 Aim of National Clinical Guideline 71.5 Scope of National Clinical Guideline, target population and target audience 71.6 Guideline Development Group 71.7 Methodology and literature review 71.8 Grading of recommendations 71.9 External review 71.10 Procedure for update of National Clinical Guideline 71.11Implementation of National Clinical Guideline 71. 12 Roles and responsibilities 71.13 Audit criteria 8
SECTION 2. NATIONAL CLINICAL GUIDELINE RECOMMENDATIONS 92.1 National recommendations. 92.2 <Content specific recommendations> 9
2.2.1 <Sub-headings> 9
SECTION 3: APPENDICES AND REFERENCES 11Appendix X: Guideline Development Group; Terms of reference, membership, conflicts of interest and contribution of members to the guideline. 11Appendix X : Summary of tools to assist in Implementation of National Clinical Guideline 12Appendix X: Literature review 12Appendix X: Details of consultation process 13Appendix X: Glossary of terms and abbreviations 14Appendix X: Budget impact assessment 15References 18
8
Section 1: Background1.1 Need for National Clinical Guideline/revised National Clinical Guideline
1.2 Clinical and financial impact of condition/disease/topic
1.3 Overview of epidemiology of condition/disease/topic
1.4 Aim of National Clinical Guideline
1.5 Scope of National Clinical Guideline, target population and target audience
1.6 Guideline Development Group<overview of types of members><sections each member was responsible for drafting><conflict of interests if any, declared and if necessary a description of how this conflict of interest was managed.<sources of funding if any, declared>
1.7 Methodology and literature review<General overview of these processes such as times and dates of meetings and any consultations with groups other than the GDG><Full methodology to be described in appendix section>
1.8 Grading of recommendations<Outline of grading structure used – refer to the NCEC Guideline Devlopement Manual for guidance>
1.9 External review<Members of external review group> <their relevant expertise outlined><the process by which they were contacted><their direct input to be outlined>
1.10 Procedure for update of National Clinical Guideline<Details of procedure for update>
1.11Implementation of National Clinical Guideline<An overview of what is required for the Implementation of this National Clinical Guideline>
<Key groups responsible for various sections of implementation>
1. 12 Roles and responsibilities
<Roles and responsibilities outlined for:Organisational responsibility
9
Other healthcare staff>
1.13 Audit criteriaTo ensure that this guideline positively impacts on patient care, it is important that implementation is audited. Audit is recommended to support continuous quality improvement in relation to the implementation of the National Clinical Guideline.
<Key audit criteria need to be outlined>
10
SECTION 2. National Clinical Guideline recommendations<summary of National recommendations>
Section Subsection <if relevant> Recommendation Number
<High level recommendations><Other more section specific recommendations>
2.1 National recommendations.
<high level recommendations>
Recommendation X<insert recommendation>Grade xx
2.2 <Content specific recommendations>
2.2.1 <Sub-headings>
The following are responsible for implementation of recommendation X: <CEO/General Manager of healthcare facility…etc.>
Recommendation X<insert recommendation> Grade X
Practical Guidance<insert for above recommendation>
Rationale<if any for the above recommendation/practical guidance.
Note:This section may not apply if there is a stated adaptation process that makes reference back to the original adapted guideline>
11
The following are responsible for implementation of recommendation X:<Healthcare facility Senior Management Team (e.g. CEO, Director of Nursing/Midwifery, Clinical Director and Director of Finance) and all healthcare staff…etc.>
Recommendation X
Grade X
Practical Guidance<insert for above recommendation>
Rationale<if any for the above recommendation/practical guidance.
Note:This section may not apply if there is a stated adaptation process that makes reference back to the original guideline>
Section 3: Appendices and References
12
Appendix X: Guideline Development Group; Terms of reference, membership, conflicts of interest and contribution of members to National Clinical Guideline.
Terms of Reference
Membership and Conflicts of InterestChair: Members:
Conflicts of Interest
Contributions
Additional Contributions and Review
13
Appendix X : Summary of tools to assist in Implementation of National Clinical Guideline
Appendix X: Literature review
<The review should be carried out using a robust methodology. The NCEC Guideline Development Manual outlines the steps necessary to carry out a systematic literature review to support clinical guideline development and should be used as a reference guide when completing this literature review.
Proposed Search strategy The scope of the literature search should encompass national and international research. A full audit trail for articles with bibliographical detail should be included.
In the first instance a search for relevant clinical guidelines should be carried out and if any are found, their quality should be appraised using the “rigour of development” domain as described by the National Quality Assurance Criteria for Clinical Guidelines (HIQA, 2011).
The parameters, i.e., population, interventions, comparisons, and outcomes (PICOs) are to be presented along with the review methodology, including the search strategy, detailed search terms and methods for quality appraisal and evidence synthesis that were used.
Evidence tables should be presented and the rationale behind the particular grade chosen for each of the recommendations should be clearly presented.>
Appendix X: Details of consultation process
14
DatePatients and members of the publicExternal review
Clinical leaders and healthcare managersNational committeesProfessional groups
15
Appendix X: Glossary of terms and abbreviations
Definitions within the context of this document<if any>
Abbreviations
<all abbreviations in the document must be stated>
Appendix 11: Budget impact assessment
Economic Impact Report
<Report completed by…>
Economic literature review results
The GDG should undertake a literature search for evidence of clinical and cost effectiveness, cost and resource impact, including primary (research studies) and secondary (reviews and economic evaluations) sources. The literature sources that will be searched should be specified in the search strategy and should include relevant resources, such as trial/guideline registries and relevant citation databases (e.g. Medline, EMBASE, Database of Abstracts of Reviews of Effects (DARE), NHS Economic Evaluation Database, Health Technology Assessment Database and Cochrane Database of Systematic Reviews). The economic literature review can be undertaken using the same search terms as derived from the clinical literature review but with the economic filter applied.
Budget impact of National Clinical Guideline
Scope of the budget -impact analysis
Overall cost implications
Possible additional cost implications of the National Clinical Guideline
Methods<The search strategy …>
Key message
Table 4 Economic FilterID Search Hits6 *Economics/ 214797 *Economics, Medical/ 215598 *Economics, Pharmaceutical/ 58729 exp "Costs and Cost Analysis"/ 40006410 exp Health Care Costs/ 22493911 exp decision support techniques/ 6477912 exp models, economic/ 10278213 markov chains.sh. 834614 montecarlo method.sh. 3551915 uncertainty.sh. 1015816 quality of life.sh. 30845217 quality-adjusted life years.sh. 595018 exp health economics/ 56418019 exp economic evaluation/ 19055320 exppharmacoeconomics/ 16077021 exp economic aspect/ 104712022 quality adjusted life year/ 1561523 quality of life/ 30845224 exp "costs and cost analyses"/ 16835225 (economic impact or economic value or pharmaco-economics or health care
cost or economic factors or cost analysis or economic analysis or cost or cost- effectiveness or cost effectiveness or costs or health care cost or cost savings or cost-benefit analysis or hospital costs or medical costs or quality-of-life).sh.
592852
26 (econom$ or cost or costly or costing or costed or price or prices or pricing or priced or discount or discounts or discounted or discounting or expenditureor expenditures or budget$ or afford$ or pharmacoeconomic or pharmaco- economic$).ti,ab.
1046158
27 (cost$ adj1 (util$ or effective$ or efficac$ or benefit$ or consequence$ oranaly$ or minimi$ or saving$ or breakdown or lowering or estimate$ or variable$ or allocation or control or illness or sharing or life or lives or affordabl$ or instrument$ or technolog$ or day$ or fee or fees or charge or charges).ti,ab.
212069
28 (decision adj1 (tree$ or analy$ or model$)).ti,ab. 2027929 ((value or values or valuation) adj2 (money or monetary or life or lives or
costs or cost)).ti,ab.8947
30 (qol or qoly or qolys or hrqol or qaly or qalys or qale or qales).ti,ab. 6355731 (sensitivity analys$s or quality-adjusted life year$ or quality adjusted life
year$ or quality-adjusted life expectanc$ or quality adjusted life expectanc$).ti,ab.
11826
32 (unit cost or unit-cost or unit-costs or unit costs or drug cost or drug costs or hospital costs or health-care costs or health care cost or medical cost or medical costs).ti,ab.
45098
33 (decision adj1 (tree$ or analy$ or model$)).ti,ab. 2027934 or/6-33 2377303
Figure X Flow chart of excluded studies for economic literature review
<use a graphic to represent numbers of excluded studies>
References for budget impact assessment
<Endnote><Harvard Style><Journal in Italics>
Form APermissions Form for Guideline Development Groups
Have all permissions been granted to reproduce any external materials/publications used in this National Clinical Guideline?
YES
NO
Please include evidence of all permissions requested by the GDG to reproduce external materials/publications used in this National Clinical Guideline.
Signature of Chair of GDG to verify that relevant permission have been sought.
__________________________________
Date:____________________________
This form is not part of the guideline template.Form BFeedback from GDG user of Summary National Clinical Guideline Template
Did you find the provision of a template useful for the completion of a National Clinical Guideline?
YES
NOWhat did you find worked well?
In your opinion, what areas of the template could be improved?